Company intelligence / Profile preview

Meprofarm

Bandung, West Java, Indonesiameprofarm.com ↗

Ownership: Private
Employees: ~384
Development stage: Other

Overview

Meprofarm is an established Indonesian pharmaceutical manufacturer with a focus on high-quality drug production, including generics such as albendazole. The company operates two main manufacturing facilities and has capabilities for both oral solid and liquid dosage forms as well as injectables, creams, suppositories/ovula. It collaborates with other pharma companies for contract manufacturing and continues to invest in R&D for new product development[5][6].

Therapeutic areas: Infectious Diseases
Modalities: Small moleculeGeneric drug
Industry: Biotech

Drug pipeline

2 assets

Boncerin

Unknown

1 more asset in the full pipeline.

Request access →

Partnerships

Collaborates with other pharmaceutical companies in Indonesia for contract/toll manufacturing

Beyond the preview

Go deeper on Meprofarm.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Meprofarm.

Explore the full profile